Quality | 2019.02.26
Intrinsic Imaging Undergoes Extensive FDA BIMO Inspection - Receives Zero 483 Observations
The FDA inspector highly praised Intrinsic Imaging’s quality management system. In particular, the inspector highlighted the robustness of Intrinsic Imaging's quality control process to ensure the accurate data transfer of independent reviewer assessments to the sponsor.
(PRWeb February 26, 2019)
Read the full story at https://www.prweb.com/releases/intrinsic_imaging_undergoes_extensive_fda_bimo_inspection_receives_zero_483_observations/prweb16125435.htm
For more information, please visit
https://www.prweb.com/releases/intrinsic[...]observations/prweb16125435.htm
